Active Ingredient: Terbutaline
Terbutaline is a selective beta2-adrenergic agonist recommended for the relief of bronchospasm in bronchial asthma and other bronchopulmonary disorders in which bronchospasm or reversible airways obstruction is a complicating factor.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Respiratory (Inhalation), 0.5 milligrams terbutaline, 1 to 4 times daily. The maximum allowed total dose is 2 milligrams terbutaline daily.
One inhalation (0.5 mg) as required. Not more than 4 inhalations should be required in any 24-hour period.
The duration of action of a single dose is up to 6 hours.
For:
Oral, 2.5 milligrams terbutaline, 2 to 3 times daily.
The starting dose should normally be 2.5mg (half a tablet) 2 times in 24 hours. However, in some patients, the dose may need to be increased to 2.5mg 3 times in 24 hours.
For:
Oral, 2.5 milligrams terbutaline, 3 times daily, over the duration of 1 to 2 weeks. Afterwards, oral, 5 milligrams terbutaline, 3 times daily.
During the first 1-2 weeks, 2.5 mg (half a tablet) 3 times in a 24-hour period is recommended. The dose may then be increased to 5 mg (1 tablet) 3 times in a 24-hour period to achieve adequate bronchodilation.
For:
Intravenous, between 0.25 milligrams terbutaline and 0.5 milligrams terbutaline, 1 to 4 times daily.
When a rapid therapeutic response is required, terbutaline can be administered by i.v. bolus. When given as an i.v. bolus the injection must be made slowly noting patient response.
0.25-0.5 mg up to four times a day.
For:
Subcutaneous, between 0.25 milligrams terbutaline and 0.5 milligrams terbutaline, 1 to 4 times daily.
When a rapid therapeutic response is required, terbutaline can be administered by subcutaneous route.
0.25-0.5 mg up to four times a day.
For:
Intramuscular, between 0.25 milligrams terbutaline and 0.5 milligrams terbutaline, 1 to 4 times daily.
When a rapid therapeutic response is required, terbutaline can be administered by intramuscular route.
0.25-0.5 mg up to four times a day.
For:
Intravenous, 0.01 milligrams terbutaline per kilogram of body weight, 1 one dose.
When a rapid therapeutic response is required, terbutaline can be administered by i.v. bolus. When given as an i.v. bolus the injection must be made slowly noting patient response.
Children 2-15 years: 0.01 mg/kg body weight to a maximum of 0.3 mg total.
| Age | Average weight | mg | |
|---|---|---|---|
| kg | (lb) | terbutaline | |
| <3 | 10 | (22) | 0.1 |
| 3 | 15 | (33) | 0.15 |
| 6 | 20 | (44) | 0.2 |
| 8 | 25 | (55) | 0.25 |
| 10+ | 30+ | (66+) | 0.3 |
For:
Subcutaneous, 0.01 milligrams terbutaline per kilogram of body weight, 1 one dose.
When a rapid therapeutic response is required, terbutaline can be administered by subcutaneous route.
Children 2-15 years: 0.01 mg/kg body weight to a maximum of 0.3 mg total.
| Age | Average weight | mg | |
|---|---|---|---|
| kg | (lb) | terbutaline | |
| <3 | 10 | (22) | 0.1 |
| 3 | 15 | (33) | 0.15 |
| 6 | 20 | (44) | 0.2 |
| 8 | 25 | (55) | 0.25 |
| 10+ | 30+ | (66+) | 0.3 |
For:
Intramuscular, 0.01 milligrams terbutaline per kilogram of body weight, 1 one dose.
When a rapid therapeutic response is required, terbutaline can be administered by intramuscular route.
Children 2-15 years: 0.01 mg/kg body weight to a maximum of 0.3 mg total.
| Age | Average weight | mg | |
|---|---|---|---|
| kg | (lb) | terbutaline | |
| <3 | 10 | (22) | 0.1 |
| 3 | 15 | (33) | 0.15 |
| 6 | 20 | (44) | 0.2 |
| 8 | 25 | (55) | 0.25 |
| 10+ | 30+ | (66+) | 0.3 |
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.